Ibuprofen Zentiva (Ibuprofen Lysine)

Ibuprofen Lysine, the active ingredient in Ibuprofen Zentiva, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is used to relieve pain, reduce fever, and diminish inflammation in adults and children when appropriate, typically under medical supervision.

GNH USA supplies Ibuprofen Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand, including bulk shipments and just‑in‑time delivery options.

Ibuprofen Lysine acts as an NSAID that reduces prostaglandin synthesis, making it effective for several common conditions such as pain, fever, and inflammatory disorders. - Pain: Provides analgesic relief for mild to moderate musculoskeletal, dental, and postoperative pain, improving functional comfort and reducing the need for additional opioid analgesics. - Fever: Lowers elevated body temperature associated with infections, viral illnesses, or inflammatory states, helping to normalize thermoregulation and may improve patient comfort during acute illness. - Inflammation: Decreases swelling, redness, and stiffness in conditions such as osteoarthritis, rheumatoid arthritis, and soft‑tissue injuries, supporting mobility and may facilitate earlier return to daily activities.

Ibuprofen Lysine may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate tension‑type headache. - Dizziness: transient light‑headedness or vertigo. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: severe abdominal pain or black stools. - Renal impairment: reduced urine output or swelling due to fluid retention. - Hypersensitivity reactions: anaphylaxis, angioedema, or severe skin reactions such as Stevens‑Johnson syndrome.

When prescribing or dispensing Ibuprofen Lysine, several precautions should be observed to minimize risk. - Assess renal function: avoid use in patients with severe renal impairment or dehydration. - Evaluate gastrointestinal risk: use with caution in individuals with a history of ulcer disease or bleeding. - Monitor cardiovascular status: consider risk in patients with hypertension, heart failure, or coronary artery disease. - Review concomitant medications: avoid concurrent use with other NSAIDs, anticoagulants, or corticosteroids without medical guidance. - Pregnancy and lactation: use only if clearly needed and after professional assessment. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Ibuprofen Lysine can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced diuretic efficacy and renal compromise. - Lithium: NSAIDs may increase lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity. - Corticosteroids: additive gastrointestinal ulcer risk.